Clinical trials
Completed Phase 1 trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
876 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 4 |
| 2003 | 5 |
| 2004 | 10 |
| 2005 | 14 |
| 2006 | 21 |
| 2007 | 24 |
| 2008 | 33 |
| 2009 | 52 |
| 2010 | 37 |
| 2011 | 57 |
| 2012 | 42 |
| 2013 | 63 |
| 2014 | 49 |
| 2015 | 47 |
| 2016 | 54 |
| 2017 | 48 |
| 2018 | 56 |
| 2019 | 45 |
| 2020 | 51 |
| 2021 | 43 |
| 2022 | 41 |
| 2023 | 28 |
| 2024 | 23 |
| 2025 | 14 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 876 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 58 |
| Novartis Pharmaceuticals | 46 |
| Radboud University Medical Center | 43 |
| Boehringer Ingelheim | 39 |
| Janssen Research & Development, LLC | 38 |
| GlaxoSmithKline | 33 |
| AstraZeneca | 25 |
| Pfizer | 24 |
| University Medical Center Groningen | 23 |
| Bayer | 19 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 88 |
| Carcinoma, Non-Small-Cell Lung | 27 |
| Breast Neoplasms | 25 |
| Alzheimer Disease | 15 |
| Ovarian Neoplasms | 15 |
| Melanoma | 14 |
| Neoplasm Metastasis | 13 |
| Arthritis, Rheumatoid | 12 |
| Colorectal Neoplasms | 12 |
| Carcinoma, Renal Cell | 10 |
Trials
Showing 1 to 25 of 876. Each trial links to its page on Pharma Observatory.
776 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.